85
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease

&
Pages 547-552 | Published online: 16 Feb 2018

References

  • Ene-IordacheBPericoNBikbovBChronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional studyLancet Glob Health201645e307e31927102194
  • JoyceATIacovielloJMNagSEnd-stage renal disease-associated managed care costs among patients with and without diabetesDiabetes Care200427122829283515562193
  • OjoAAddressing the global burden of chronic kidney disease through clinical and translational researchTrans Am Clin Climatol Assoc2014125122924625125737
  • Duran-SalgadoMBRubio-GuerraAFDiabetic nephropathy and inflammationWorld J Diabetes20145339339824936261
  • MataDARamosMABansalNKhanRGuilleCDi AngelantonioESenSPrevalence of depression and depressive symptoms among resident physicians: a systematic review and meta-analysisJAMA2015314222373238326647259
  • ChenJJZhouCJZhengPDifferential urinary metabolites related with the severity of major depressive disorderBehav Brain Res201733228028728624318
  • ChenJJZengBHLiWWEffects of gut microbiota on the microRNA and mRNA expression in the hippocampus of miceBehav Brain Res2017322Pt A344128093256
  • KopWJSeligerSLFinkJCLongitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomesClin J Am Soc Nephrol20116483484421393483
  • HedayatiSSJiangWO’ConnorCMThe association between depression and chronic kidney disease and mortality among patients hospitalized with congestive heart failureAm J Kidney Dis200444220721515264178
  • LeeYJKimMSChoSKimSRAssociation of depression and anxiety with reduced quality of life in patients with predialysis chronic kidney diseaseInt J Clin Pract201367436336823521328
  • TheofilouPQuality of life in patients undergoing hemodialysis or peritoneal dialysis treatmentJ Clin Med Res20113313213821811544
  • StasiakCEBazanKSKussRSSchuinskiAFBaroniGPrevalence of anxiety and depression and its comorbidities in patients with chronic kidney disease on hemodialysis and peritoneal dialysisJ Bras Nefrol201436332533125317615
  • CukorDCoplanJBrownCAnxiety disorders in adults treated by hemodialysis: a single-center studyAm J Kidney Dis200852112813618440682
  • KangRHeYYanYComparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trialNeuropsychiatr Dis Treat2015111307131126064049
  • WangXShenBZhuangXWangXWengWInvestigating factors associated with depressive symptoms of chronic kidney diseases in china with type 2 diabetesJ Diabetes Res20172017176989728261621
  • GBD 2013 Mortality and Causes of Death CollaboratorsGlobal, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013Lancet2015385996311717125530442
  • BrosnahanGFraerMManagement of chronic kidney disease: what is the evidence?South Med J2010103322223020134375
  • PorterACVijilJCJrUnruhMLoraCLashJPHealth-related quality of life in Hispanics with chronic kidney diseaseTransl Res2010155415716320303462
  • PascoeMCThompsonDRCastleDJMcEvedySMSkiCFPsychosocial interventions for depressive and anxiety symptoms in individuals with chronic kidney disease: systematic review and meta-analysisFront Psychol2017899228659852
  • JheeJHKimHParkSVitamin D deficiency is significantly associated with depression in patients with chronic kidney diseasePLos One2017122e017100928192445
  • ZhuFXZhangXYDingXKHanBProtective effect of regular physical activity on major depressive episodes in patients with early stages of chronic kidney diseaseRen Failure2017391602606
  • HedayatiSSGreggLPCarmodyTEffect of sertraline on depressive symptoms in patients with chronic kidney disease without dialysis dependence: the CAST randomized clinical trialJAMA2017318191876189029101402